I 112th CONGRESS 2d Session H. R. 5364 IN THE HOUSE OF REPRESENTATIVES May 7, 2012 Mr. Dold introduced the following bill; which was referred to the Committee on Ways and Means A BILL To suspend temporarily the duty on placebos to be used in clinical trials for the drug ASKP1240.

1.

Placebos to be used in clinical trials for the drug ASKP1240

(a)

In general

Subchapter II of chapter 99 of the Harmonized Tariff Schedule of the United States is amended by inserting in numerical sequence the following new heading: 9902.01.00Placebos, composed of sodium L-glumate, D-sorbitol, and polysorbate 80, to be used in clinical trials for the drug ASKP1240 (provided for in subheading 3824.90.92)FreeNo changeNo changeOn or before 12/31/2015 . (b)

Effective date

The amendment made by subsection (a) applies to goods entered, or withdrawn from warehouse for consumption, on or after the 15th day after the date of the enactment of this Act.